Vidcast: https://www.instagram.com/p/CtvlCX9JloY

Nearly half (49.1%) of those using ketamine nasal spray called it “very effective and more than a third (35.5%) described their lives as “much better.”   

Neurologists at Philadelphia’s Thomas Jefferson University’s headache center screened 242 subjects, 80% of whom were women with a mean age of 44 years.  Their descriptive study found that the participants used, on average, 6 sprays of ketamine a day for about 10 days a month.  Two-thirds of the subjects were so satisfied that they remained intranasal ketamine users after the study ended.

This preliminary study is an exciting beginning offering yet another modality for control of migraine headaches, a disease affecting more than 39 million Americans and more than a billion people worldwide.

https://rapm.bmj.com/content/early/2023/05/03/rapm-2022-104223

https://www.singlecare.com/blog/news/migraine-statistics/

#migraines #ketamine #nasalspray